NCT00000344View on ClinicalTrials.gov

Buprenorphine/Naloxone for Treatment of Opiate Dependence - 9

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

Not specified

Study Completion Date

August 31, 2000

Conditions
Opioid-Related Disorders
Interventions
DRUG

Buprenorphine/naloxone

Trial Locations (1)

90025

Friends Research Institute, Los Angeles

All Listed Sponsors
lead

National Institute on Drug Abuse (NIDA)

NIH

NCT00000344 - Buprenorphine/Naloxone for Treatment of Opiate Dependence - 9 | Biotech Hunter | Biotech Hunter